[188 Pages Report] The Biobanking Market size was estimated at USD 70.33 billion in 2023 and expected to reach USD 78.21 billion in 2024, at a CAGR 11.71% to reach USD 152.75 billion by 2030.
Biobanking involves the collection, storage, management, processing, and distribution of biological samples from humans and animals for research and clinical purposes. It serves various sectors, including pharmaceuticals, biotechnology companies, academic institutions, and healthcare organizations. Applications include drug discovery, diagnostics development, personalized medicine research, and biomarker identification. Rising chronic disease prevalence such as cancer requires early detection and treatment methodologies and necessitates efficient sample storage, increasing deployment of biobanking. Moreover, increasing focus on precision medicine and government investments in national biobank networks are propelling the growth of the market. Furthermore, ensuring sample quality control and maintaining standardized protocols in collecting, processing, and storing samples are major concerns, as inconsistencies can lead to unreliable research outcomes. Data privacy is another pressing issue, with an increasing number of biobanks handling sensitive patient information. Also, leveraging emerging technologies including robotics automation systems for sample handling, enhancing data security through digitalization using blockchain technology, and implementing environmentally sustainable practices including energy-efficient storage units create lucrative opportunities for market growth.
Regional Insights
In the Americas, the US biobanking industry plays a pivotal role in advancing biomedical research through initiatives such as the National Institutes of Health’s All of Us Research Program. Furthermore, investments from state governments are driving the establishment of new biobanks. The EU biobanking market is bolstered by collaborations among various countries under initiatives such as Biobanking and BioMolecular resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC). Additionally, funding programs, including Horizon 2020, have facilitated advancements in personalized medicine. In Africa, initiatives including H3Africa have promoted the development of biorepositories across the continent to support genomics research on African populations. The APAC region is experiencing rapid growth due to government policies that allocate funds for medical innovation and precision medicine. India hosts several regional biobanks focusing on disease-specific applications such as cancer research.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biobanking Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biobanking Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L’AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..
Market Segmentation & Coverage
This research report categorizes the Biobanking Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Consumables
- Equipment & Instruments
- Services
- Software
- Sample Type
- Biological Fluids
- Blood Products
- Cell Lines
- Human Tissues
- Nucleic Acids
- Storage Type
- Automated
- Manual
- Application
- Clinical Research
- Life Science Research
- Regenerative Medicine
- End-User
- Academic & Research Institutes
- Hospitals
- Pharmaceutical & Biotechnology
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Biobanking Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biobanking Market?
- What are the technology trends and regulatory frameworks in the Biobanking Market?
- What is the market share of the leading vendors in the Biobanking Market?
- Which modes and strategic moves are suitable for entering the Biobanking Market?
US $
Euro €
GBP £